SLC5A2 and Hyperinsulinemia: Since hyperinsulinemia and increased insulin resistance promote macrovascular and microvascular complications [60], SGLT-2 inhibitors with their highly beneficial metabolic effects could be hypothesized to provide a novel treatment option also for DR.